Changes in the biogenic amine content of the prefrontal cortex, amygdala, dorsal hippocampus, and nucleus accumbens of rats submitted to single and repeated sessions of the elevated pluz-maze test

Brazilian Journal of Medical and Biological Research

Volumn 38, Issue 12, 2005, Pages 1857-1866

  Carvalho, M C ^a   Albrechet Souza, L ^a   Masson, S ^a   Brandao M L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Amygdala; Dopamine; Hippocampus; One trial tolerance; Prefrontal cortex; Serotonin

Indexed keywords

BIOGENIC AMINE; DOPAMINE; MIDAZOLAM; SEROTONIN; SODIUM CHLORIDE;

AMYGDALOID NUCLEUS; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HIPPOCAMPUS; MALE; MAZE TEST; MONOAMINERGIC SYSTEM; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RAT; STIMULUS RESPONSE; STRESS;

ANIMALIA;

EID: 30544440547     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2005001200014     Document Type: Article

References (36)

1. Maisonnette SS, Morato S & Brandão MIL (1993). Role of resocialization and of 5-HT 1A receptor activation on the anxiogenic effects induced by isolation in the elevated plus maze test. Physiology and Behavior, 54: 753-758.
2. Maritjena ID, Calvo N, Volosin M et al. (1997). Prior exposure to a brief restraint session facilitates the occurrence of fear in response to a conflict situation: behavioral and neurochemical correlates. Brain Research, 752: 136-142.
3. Graeff FG & Deakin JFW (1991). 5-HT and mechanisms of defence. Journal of Psychopharmacology, 5: 305-315.
4. Gray JA & McNaughton N (2000). Fundamentals of the septohippocampal system. In: Gray JA & McNaughton N (Editors), Neuropsychology of Anxiety. 2nd edn. Oxford University Press, Oxford, UK.
5. Handley SL & McBlane JW (1993). 5-HT drugs in animal models of anxiety. Psychopharmacology, 112: 13-20.
6. File SE & Zangrossi H (1993). "One trial tolerance" to the anxiolytic actions of benzodiazepine in the elevated plus-maze, or the development of a phobic state? Psychopharmacology, 110: 240-244.
7. Bertoglio LJ & Carobrez AP (2000). Previous maze experience required to increase open arms avoidance in rats submitted to the elevated plus-maze model of anxiety. Behavioural Brain Research, 108: 197-203.
8. Bertoglio LJ & Carobrez AP (204). Scopolamine given pre-trial 1 prevents the one-trial tolerance phenomenon in the elevated plusmaze trial 2. Behavioural Pharmacology, 15: 45-54.
9. Cruz-Morales SE, Santos NR & Brandão ML (2002). One-trial tolerance to midazolam is due to enhancement of fear and reduction of anxiolytic-sensitive behaviors in the elevated plus-maze retest in the rat. Pharmacology, Biochemistry, and Behavior, 72: 973-978.
10. Cuadra G, Zurita A, Lacerra C et al. (1999). Chronic stress sensitizes frontal cortex dopamine release in response to a subsequent novel stressor: reversal by naloxone. Brain Research Bulletin, 48: 303-308.
11. Cuadra G, Zurita A, Macedo CE et al. (2000). Electrical stimulation of the midbrain tectum enhances dopamine release in the frontal cortex. Brain Research Bulletin, 52: 413-418.
12. Zurita A, Maritjena I, Cuadra G et al. (2000). Early exposure to chronic variable stress facilitates the occurrence of anhedonia and enhanced emotional reactions to novel stressors: reversal by naltrexone pretreatment. Behavioural Brain Research, 117: 163-171.
13. Jackson ME & Moghaddam B (2001). Amygdala regulation of nucleus accumbens dopamine output is governed by the prefrontal cortex. Journal of Neuroscience, 21: 676-681.
14. Gallagher M & Holland P (1994). The amygdala complex: Multiple roles in associative learning and attention. Proceedings of the National Academy of Sciences, USA, 1: 11771-11776.
15. Mogenson G, Jones D & Yim C (1980). From motivation to action: functional interface between the limbic system and the motor system. Progress in Neurobiology, 14: 69-97.
16. Goldstein LE, Rasmusson AM, Bunney BS et al. (1996). Role of the amygdala in the coordination of behavioral, neuroendocrine, and prefrontal cortical monoamine responses to psychological stress in the rat. Journal of Neuroscience, 16: 4787-4798.
17. Mongeau R, Blier P & de Montigny C (1997). The serotoninergic and noradrenergic systems of the hippocampus: their interactions and the effects of antidepressant treatments. Brain Research Reviews, 23: 145-195.
18. Feenstra MGP, Botterblom MHA & Van Uum JFM (1995). Novelty-induced increase in dopamine release in the rat prefrontal cortex in vivo: Inhibition by diazepam. Neuroscience Letters, 189: 81-84.
19. Anseloni VCZ & Brandão ML (1997). Ethopharmacological analysis of behaviour of rats using variations of the elevated plus-maze. Behavioural Pharmacology, 8: 533-540.
20. Albrechet-Souza L, Oliveira AR, DeLuca MGZ et al. (2005). A comparative study with two types of elevated plus-maze (transparent vs opaque walls) on the effects of midazolam, one-trial tolerance and fear-induced analgesia. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 29: 571-579.
21. Paxinos G & Watson C (1997). The Rat Brain in Stereotaxic Coordinates. Academic Press, New York.
22. Dominguez R, Cruz-Morales SE, Carvalho MC et al. (2003). Sex differences in serotonergic activity in dorsal and median raphe nucleus, Physiology and Behavior, 80: 203-210.
23. Dominguez R, Cruz-Moralez SE, Carvalho MC et al. (2003). Effect of steroid injection to newborn rats on serotonin activity in frontal cortex and raphe. NeuroReport, 14: 597-599.
24. Rodgers RJ & Shepherd JK (1993). Influence of prior maze experience on behaviour and response to diazepam in the elevated plus-maze and light/ dark tests of anxiety in mice. Psychopharmacology, 113: 237-242.
25. Dawson GR, Crawford SP, Stanhope KJ et al. (1994). One-trial tolerance to the effects of chlordiazepoxide on the elevated plus-maze may be due to locomotor habituation, not repeated drug exposure. Psychopharmacology, 113: 570-572.
26. Antelman SM, Cunnick JE, Lysle DT et al.(1990). Immobilization 12 days (but not one hour) earlier enhanced 2-deoxy-D-glucose induced immunosuppression; evidence for stressor-induced time dependent sensitization of the immune system. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 14: 579-590.
27. Amat J, Amat PM, Watkins LR et al. (1998). Escapable and inescapable stress differentially alter extracellular levels of 5-HT in the basolateral amygdala of the rat. Brain Research, 812: 113-120.
28. Inglis FM & Moghaddam B (1999). Dopaminergic innervation of the amygdala is highly responsive to stress. Journal of Neurochemistry, 72: 1088-1094.
29. Gifkins A, Greba Q & Kokkinidis L (2002). Ventral tegmental area dopamine neurons mediate the shock sensitization of acoustic startle: A potential site of action for benzodiazepine anxiolytics. Behavioral Neuroscience, 116: 785-794.
30. Greba Q, Gifkins A & Kokkinidis L (2001). Inhibition of amygdaloid dopamine D2 receptors impairs emotional learning measured with fear-potentiated startle. Brain Research, 899: 219-226.
31. Sesack SR & Pickel VM (1992). Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminal in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. Journal of Comparative Neurology, 320: 145-160.
32. Goldstein LE, Rasmusson AM, Bunney BS et al. (1994). The NMDA glycine site antagonist (+)-HA-966 selectively regulates conditioned stress-induced metabolic activation of the mesoprefrontal cortical dopamine but not serotonin systems: a behavioral, neuroendocrine, and neurochemical study in the rat. Journal of Neuroscience, 14: 4937-4950.
33. Milian MJ (2003). The neurobiology and control of anxious states. Progress in Neurobiology, 70: 83-244.
34. Morrow BA, Elsworth JD, Rasmusson AM et al. (1999). The role of mesofrontal dopamine neurons in the acquisition and expression of conditioned fear in the rat. Neuroscience, 92: 553-564.
35. Charney DS, Deutch AY, Krystal JH et al. (1993). Psychobiologic mechanisms of posttraumatic stress disorder. Archives of General Psychiatry, 50: 294-305.
36. Post RM (1992). Transduction of psychosocial stress into the neurobiology of recurrent affective disorder. American Journal of Physiology, 149: 999-1010.